North China Pharmaceutical Company.Ltd(600812) release performance forecast. The company expects to realize the net profit attributable to the shareholders of the listed company of about 20 million yuan in 2021, a year-on-year decrease of about 79.45%. The performance reduction of the company is mainly due to the decrease of non recurring profit and loss events such as government subsidies included in the current profit and loss, with an impact amount of about 80 million yuan.
© China Stock Market News